Mustafa Qureshi, MD

  • 2Articles
  • 34.7KReads
  • 2019–2023Active
  • 17Collaborators
  • 35Citations

About

Mustafa Qureshi, MD, is affiliated with the Department of Psychiatry at Indiana University Ball Memorial Hospital in Muncie, Indiana. Qureshi has published research on psychiatric comorbidities in patients with neurofibromatosis and on the effectiveness of gabapentin for managing cravings and withdrawal symptoms in alcohol use disorder. The author’s work, appearing between 2019 and 2023, focuses primarily on addiction-related topics.

Publications

PCC
Psychiatric Comorbidities of Neurofibromatosis
Original Research

Psychiatric Comorbidities of Neurofibromatosis

October 3, 2023

Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
, , , et al
PCC
Meta-Analysis

Gabapentin and Withdrawal in Alcohol Use Disorder

August 22, 2019

While benzodiazepines are considered the standard of care for alcohol withdrawal, gabapentin is a valuable alternative that can also help with cravings and abstinence long term. Read on to...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe